Chimes N25

Curantil N25: An effective antiplatelet agent from Germany

Curantil N25, also known by the international name Dipyridamole, is a pharmacological drug from the group of antiplatelet agents. It is produced in Germany by Berlin-Chemie AG and Menarini Group. Curantil N25 has a wide spectrum of action and is used in various fields of medicine.

Curantil N25 is presented in the form of film-coated tablets containing 25 mg of dipyridamole each. Dipyridamole is the active ingredient of the drug. It has an antiplatelet effect, i.e. prevents platelet clotting and blood clot formation.

The use of Curantil N25 is recommended in the following cases:

1. Prevention of thromboembolic syndrome after heart valve replacement surgery.
2. Prevention of occlusion of stents and coronary artery bypass grafts (in combination with aspirin).
3. Treatment and prevention of peripheral vascular lesions.
4. Prevention of placental insufficiency during complicated pregnancy.
5. Treatment and prevention of disseminated intravascular coagulation syndrome in children with infectious toxicosis and septicemia.
6. Three-component treatment of glomerulonephritis.
7. Treatment of platelet suppression syndrome in children.
8. Carrying out dipyridamole-thallium-201 perfusion scintigraphy with physical activity.
9. Dipyridamole stress echocardiography.

Curantil N25 has some contraindications that must be taken into account when using it. It is not recommended in case of hypersensitivity to dipyridamole or other components of the drug. Its use should also be avoided in acute myocardial infarction, severe atherosclerotic lesions of coronary vessels with a developed collateral system, severe arterial hypertension, hemorrhagic diathesis, obstructive pulmonary diseases, as well as in the second and third trimesters of pregnancy and in children under 12 years of age.

When using Curantil N25, some side effects may occur. These may include nausea, abdominal discomfort, facial flushing, coronary steal syndrome (exacerbation of coronary heart disease), headaches, dizziness, bleeding, hypotension, thrombo. This is an incomplete answer that is interrupted by the word “thrombo.” Sorry for the inconvenience. Here's the continuation:

...boembolic complications. If any side effects occur, you should consult your doctor.

The dosage of Curantyl N25 depends on the indications and individual characteristics of the patient. It is usually recommended to take 1-2 tablets two to three times a day after meals. The duration of treatment is also determined by the doctor.

It is important to remember that this answer is based on information available at the time of my course in September 2021. For more up-to-date information and recommendations, you should always consult a healthcare professional or consult the official information provided by the drug manufacturer.